Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-8.86x4.13x-0.23x3.93x-7.25x-6.81x-.--% 2.2B
17.43x1.98x-2.11x3.76x10.2x11.22x0.59% 67.46B
25.46x3.82x1.98x5.22x15.33x19.12x0.62% 51.13B
34.63x6.96x0.67x11.76x22.48x26.19x-.--% 43.4B
-45.31x2.47x0.35x3.19x9.44x11.01x3.39% 40.32B
34.82x1.65x-1.1x3.61x11.84x13.64x-.--% 30.86B
-7.73x4.69x-0.4x11.07x-6.8x-6.42x-.--% 26.59B
33.48x3.32x-0.72x3.12x9.55x11.51x-.--% 22.82B
61.71x5.7x0.37x6.26x43.08x42.21x-.--% 19.79B
25.61x3.6x0.02x5.29x14.16x19.53x-.--% 16.47B
-37.83x-6.63x0.9x17.69x-53.69x-56.13x-.--% 16.29B
-111.53x12091.1x2.51x11.86x-85.1x-118.51x-.--% 11.75B
16.81x - 0.18x3.58x13.12x15.73x-.--% 11.44B
57.91x23.61x0.55x35.1x49.64x51.2x0.16% 11.35B
47.46x - 3.97x - - - -.--% 10.71B
70.98x5.02x-0.91x - - - - 6.73B
11.72x1.02x0.41x1.8x7.26x9.73x2.86% 6.15B
28.11x - 1.38x7.55x20.02x23.91x0.37% 5.73B
14.18x1.3x-0.21x2.49x6.45x7.82x1.59% 5.69B
-44.64x - -0.8x - - - - 5.63B
Average 11.22x 759.61x 0.34x 8.08x 4.69x 4.41x 0.53% 20.63B
Weighted average by Cap. 13.05x 378.37x 0.10x 7.17x 8.57x 9.41x 0.6%
Biopharmaceuticals